A couple shares how open communication reshaped their relationship during and after liver cancer treatment. Paul McKenzie, a liver cancer survivor, and his wife, Emma, sat down with CURE for a ...

For many, a diagnosis of stage 4 metastatic breast cancer can feel like a closing chapter. But for Casey Liening, diagnosed at age 32 after a grueling two-year battle to have her ...

A home-infusion model combining remote physiologic monitoring, virtual command center supervision, and in-home nursing enabled delivery of 93 IV chemotherapy infusions without infusion reactions or ...

As of 2025, there are over 18.6 million cancer survivors in the United States, representing about 1 in 18 Americans. By the ...

Frontline nivolumab plus AVD reduced risk of progression or death by 58% versus brentuximab vedotin plus AVD (PFS HR, 0.42) in advanced-stage classical Hodgkin lymphoma. CA209-8UT randomized 994 ...

For Kathy Small Wrice, a 20-year journey with multiple myeloma began not with a clear answer, but with a persistent intuition.

For patients with metastatic disease, referrals were more often related to cancer-specific concerns, including existential or end-of-life thoughts. This reflects how emotional needs may evolve as the ...

Shondia McFadden-Sabari of Bold and Breastless shares how intuition and early detection saved her life during a dual breast cancer diagnosis. At the 49th Annual Miami Breast Cancer Conference, the air ...

For Kathy Small Wrice, a 20-year journey with multiple myeloma began not with a clear answer, but with a persistent intuition. Following her dream wedding in Malta, the Minneapolis native faced a ...

Paul, a liver cancer survivor, and his wife Emma share their journey of recovery, caregiving and finding balance in life ...

Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting ...

Earlier deployment of ARPIs, PARP inhibitors, and PSMA radioligand therapy yields deeper initial control but creates heavily pretreated mCRPC with complex resistance and cumulative toxicity ...